ADME 毒理学测试市场规模、份额和成长分析（按方法、技术、应用、最终用户和地区）- 产业预测 2025-2032

2023 年 ADME 毒理学测试市场规模价值 104 亿美元，预计将从 2024 年的 116.5 亿美元增长到 2032 年的 288.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 12.0%。

ADME 毒性测试市场在评估物质的药物动力学和药物动力学方面发挥着至关重要的作用，这对于药物开发和安全性评估至关重要。随着製药公司转向这些测试以满足严格的监管要求并确保患者安全，对更安全、更有效药物的需求正在推动市场成长。儘管市场动态强劲，但挑战仍然存在，包括人体生理的复杂性、成本限制和不断变化的监管准则。然而，体外和电脑测试方法的进步以及个人化医疗的兴起也带来了光明的机会。在技​​术创新和法规遵循的推动下，美国ADME 毒性测试市场预计将在未来预测期内持续成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

ADME 毒性测试市场规模（按方法和复合年增长率） (2025-2032)

• 市场概况
• 细胞检测
• 生化分析
• 二氧化硅
• 体外

ADME 毒性测试市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 细胞培养
• 高吞吐量
• 分子影像
• 体学技术

ADME 毒性测试市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 全身毒性
• 肾毒性
• 肝毒性
• 神经毒性
• 其他的

ADME 毒性测试市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院和诊所
• 诊断中心
• 病理实验室
• 其他的

ADME 毒性测试市场规模（按地区划分）及复合年增长率（2025-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Charles River Laboratories（USA）
• Eurofins Scientific（Luxembourg）
• WuXi AppTec（China）
• SGS SA（Switzerland）
• PPD（USA）
• Covance Inc.（USA）
• ICON plc（Ireland）
• LabCorp（USA）
• Syneos Health（USA）
• IQVIA（USA）
• Boehringer Ingelheim（Germany）
• Merck & Co.（USA）
• Pfizer Inc.（USA）
• Novartis AG（Switzerland）
• AstraZeneca（UK）
• GlaxoSmithKline plc（UK）
• Sanofi（France）
• Johnson & Johnson（USA）
• AbbVie Inc.（USA）
• Eli Lilly and Company（USA）

结论和建议

ADME Toxicology Testing Market size was valued at USD 10.4 billion in 2023 and is poised to grow from USD 11.65 billion in 2024 to USD 28.84 billion by 2032, growing at a CAGR of 12.0% during the forecast period (2025-2032).

The ADME toxicology testing market plays a crucial role in evaluating the pharmacokinetics and toxicokinetics of substances, critical for drug development and safety assessments. Demand for safer and more effective drugs drives market growth, as pharmaceutical companies lean on these tests to meet stringent regulatory requirements and ensure patient safety. Despite the robust market dynamics, challenges such as human physiological complexities, cost constraints, and evolving regulatory guidelines persist. However, there are promising opportunities in advancements in in vitro and in silico testing methods, as well as the rise of personalized medicine. The US ADME Toxicology Testing Market is projected to experience sustainable growth over the next forecast period, indicating a solid trajectory driven by innovation and regulatory compliance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Adme Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Adme Toxicology Testing Market Segments Analysis

Global ADME Toxicology Testing Market is segmented by Method, Technology, Application, End Users and region. Based on Method, the market is segmented into Cellular Assay, Biochemical Assay, In Silica and Ex-vivo. Based on Technology, the market is segmented into Cell Culture, High Throughput, Molecular Imaging and OMICS Technology. Based on Application, the market is segmented into Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Others. Based on End Users, the market is segmented into Hospitals and clinics, Diagnostic centers, Pathological Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Adme Toxicology Testing Market

In 2022, the pharmaceutical sector saw a significant increase in drug development activities, spurred by the demand for novel therapeutics targeting various health conditions. This intensification in drug discovery and development significantly propelled the ADME toxicology testing market. Pharmaceutical companies and research institutions relied heavily on toxicology assessments to evaluate the safety and effectiveness of their drug candidates, ensuring rigorous safety protocols before moving forward with clinical trials and eventual market entry. Consequently, the heightened emphasis on innovative drug solutions has fostered substantial growth in the ADME toxicology testing market, underscoring its critical role in the drug development process.

Restraints in the Adme Toxicology Testing Market

The ADME Toxicology Testing market faces notable restraints primarily due to the substantial costs involved in various experimental processes, specialized equipment, and the need for skilled personnel. In 2022, these financial burdens significantly impacted the market's growth potential, especially for small to medium-sized pharmaceutical companies operating with constrained budgets. The high expenses associated with ADME toxicology testing can deter investment and limit opportunities for innovation among these smaller firms, ultimately slowing the overall advancement and expansion of the market. Thus, the financial implications remain a critical barrier to growth within this sector, necessitating strategic solutions to mitigate these challenges.

Market Trends of the Adme Toxicology Testing Market

The Adme Toxicology Testing market is experiencing a significant shift towards in vitro and in silico testing advancements, which gained substantial traction in 2022. These innovative methodologies provide cost-effective, efficient, and ethical alternatives to traditional animal testing, propelling the industry toward more humane practices. The growing emphasis on regulatory compliance and risk assessment has catalyzed the development of sophisticated in vitro assays and predictive modeling techniques, enhancing the accuracy and reliability of toxicology evaluations. As stakeholders increasingly prioritize sustainability and ethical considerations, the market is poised for sustained growth, driven by the continued integration of cutting-edge technologies in toxicological assessments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global ADME Toxicology Testing Market Size by Method & CAGR (2025-2032)

• Market Overview
• Cellular Assay
• Biochemical Assay
• In Silica
• Ex-vivo

Global ADME Toxicology Testing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Cell Culture
• High Throughput
• Molecular Imaging
• OMICS Technology

Global ADME Toxicology Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Others

Global ADME Toxicology Testing Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals and clinics
• Diagnostic centers
• Pathological Labs
• Others

Global ADME Toxicology Testing Market Size & CAGR (2025-2032)

• North America (Method, Technology, Application, End Users)
  • US
  • Canada
• Europe (Method, Technology, Application, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Technology, Application, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Technology, Application, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Technology, Application, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations